Serveur d'exploration sur les relations entre la France et l'Australie - Analysis (UK)

Index « Auteurs » - entrée « Stephen Harrap »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Stephen Harland < Stephen Harrap < Stephen Hellens  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 13.
Ident.Authors (with country if any)Title
000153 (2017) Emily R. Atkins [Royaume-Uni] ; Yoichiro Hirakawa ; Abdul Salam ; Mark Woodward ; Mark Cooper ; Pavel Hamet ; Stephen Harrap ; Kennedy Lees ; Lisheng Liu ; Giuseppe Mancia ; Michel Marre ; Vlado Perkovic ; Neil Poulter ; Bryan Williams ; John Chalmers ; Anthony RodgersSide effects and tolerability of combination blood pressure lowering according to blood pressure levels: an analysis of the PROGRESS and ADVANCE trials.
000598 (2017) Kamel Mohammedi [Australie, France] ; Mark Woodward [Australie, Royaume-Uni, États-Unis] ; Michel Marre [France] ; Stephen Colagiuri [Australie] ; Mark Cooper ; Stephen Harrap ; Giuseppe Mancia [Italie] ; Neil Poulter [Royaume-Uni] ; Bryan Williams [Royaume-Uni] ; Sophia Zoungas [Australie] ; John Chalmers [Australie]Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes
000927 (2016) Kamel Mohammedi [Australie] ; Mark Woodward [Australie, Royaume-Uni, États-Unis] ; Yoichiro Hirakawa [Australie] ; Sophia Zoungas [Australie] ; Stephen Colagiuri [Australie] ; Pavel Hamet [Canada] ; Stephen Harrap ; Neil Poulter [Royaume-Uni] ; David R. Matthews [Royaume-Uni] ; Michel Marre [France] ; John Chalmers [Australie]Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study
000999 (2016) Kamel Mohammedi [Australie] ; Mark Woodward [États-Unis] ; Yoichiro Hirakawa [Australie] ; Sophia Zoungas [Australie] ; Bryan Williams [Royaume-Uni] ; Liu Lisheng [République populaire de Chine] ; Anthony Rodgers [Australie] ; Giuseppe Mancia [Italie] ; Bruce Neal [Australie] ; Stephen Harrap [Australie] ; Michel Marre [France] ; John Chalmers [Australie]Microvascular and Macrovascular Disease and Risk for Major Peripheral Arterial Disease in Patients With Type 2 Diabetes.
000A33 (2016) Muh Geot Wong [Australie] ; Vlado Perkovic [Australie] ; John Chalmers [Australie] ; Mark Woodward [États-Unis] ; Qiang Li [Australie] ; Mark E. Cooper [Australie] ; Pavel Hamet [Canada] ; Stephen Harrap [Australie] ; Simon Heller [Royaume-Uni] ; Stephen Macmahon [Royaume-Uni] ; Giuseppe Mancia [Italie] ; Michel Marre [France] ; David Matthews [Royaume-Uni] ; Bruce Neal [Royaume-Uni] ; Neil Poulter [Royaume-Uni] ; Anthony Rodgers [Australie] ; Bryan Williams [Royaume-Uni] ; Sophia Zoungas [Australie]Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON.
000B85 (2016) Joep Van Der Leeuw [Pays-Bas] ; Frank L J. Visseren [Pays-Bas] ; Mark Woodward [Australie] ; Yolanda Van Der Graaf [Pays-Bas] ; Diederick E. Grobbee [Pays-Bas] ; Stephen Harrap [Australie] ; Simon Heller [Royaume-Uni] ; Giuseppe Mancia [Italie] ; Michel Marre [France] ; Neil Poulter [Royaume-Uni] ; Sophia Zoungas [Australie] ; John Chalmers [Australie]Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes.
001479 (2014) Paul Welsh [Royaume-Uni] ; Mark Woodward [Australie] ; Graham S. Hillis [Australie] ; Qiang Li [Australie] ; Michel Marre [France] ; Bryan Williams [Royaume-Uni] ; Neil Poulter [Royaume-Uni] ; Louise Ryan [Australie] ; Stephen Harrap [Australie] ; Ansuhka Patel [Australie] ; John Chalmers [Australie] ; Naveed Sattar [Royaume-Uni]Do cardiac biomarkers NT-proBNP and hsTnT predict microvascular events in patients with type 2 diabetes? Results from the ADVANCE trial.
001492 (2014) Hisatomi Arima [Australie] ; Craig Anderson [Australie] ; Teruo Omae [Japon] ; Mark Woodward [Australie] ; Stephen Macmahon [Royaume-Uni] ; Giuseppe Mancia [Italie] ; Marie-Germaine Bousser [France] ; Christophe Tzourio [France] ; Stephen Harrap [Australie] ; Lisheng Liu [République populaire de Chine] ; Bruce Neal [Australie] ; John Chalmers [Australie]Degree of blood pressure reduction and recurrent stroke: the PROGRESS trial.
001720 (2014) Sophia Zoungas [Australie] ; Mark Woodward [Australie, États-Unis] ; QIANG LI [Australie] ; Mark E. Cooper [Australie] ; Pavel Hamet [Canada] ; Stephen Harrap [Australie] ; Simon Heller [Royaume-Uni] ; Michel Marre [France] ; Anushka Patel [Australie] ; Neil Poulter [Royaume-Uni] ; Bryan Williams [Royaume-Uni] ; John Chalmers [Australie]Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes
001750 (2014) Paul Welsh [Royaume-Uni] ; Mark Woodward [Australie] ; Graham S. Hillis [Australie] ; QIANG LI [Australie] ; Michel Marre [France] ; Bryan Williams [Royaume-Uni] ; Neil Poulter [Royaume-Uni] ; Louise Ryan [Australie] ; Stephen Harrap [Australie] ; Ansuhka Patel [Australie] ; John Chalmers [Australie] ; Naveed Sattar [Royaume-Uni]Do Cardiac Biomarkers NT-proBNP and hsTnT Predict Microvascular Events in Patients With Type 2 Diabetes? Results From the ADVANCE Trial
001769 (2014) Gordon Lowe [Royaume-Uni] ; Mark Woodward [Australie] ; Graham Hillis [Australie] ; Ann Rumley [Royaume-Uni] ; QIANG LI [Australie] ; Stephen Harrap [Australie] ; Michel Marre [France] ; Pavel Hamet [Canada] ; Anushka Patel [Australie] ; Neil Poulter [Royaume-Uni] ; John Chalmers [Australie]Circulating Inflammatory Markers and the Risk of Vascular Complications and Mortality in People With Type 2 Diabetes and Cardiovascular Disease or Risk Factors: The ADVANCE Study
002526 (2011) Jasper J. Brugts [Pays-Bas] ; Aaron Isaacs [Pays-Bas] ; Moniek P. M. De Maat [Pays-Bas] ; Eric Boersma [Pays-Bas] ; Cock M. Van Duijn [Pays-Bas] ; K. Martijn Akkerhuis [Pays-Bas] ; Andre G. Uitterlinden [Pays-Bas] ; Jacqueline C. M. Witteman [Pays-Bas] ; Francois Cambien [France] ; Claudio Ceconi [Italie] ; Willem Remme [Pays-Bas] ; Michel Bertrand [France] ; Toshiharu Ninomiya [Australie] ; Stephen Harrap [Australie] ; John Chalmers [Australie] ; Stephen Macmahon [Australie] ; Kim Fox [Royaume-Uni] ; Roberto Ferrari [Italie] ; Maarten L. Simoons [Pays-Bas] ; A. H. Jan Danser [Pays-Bas]A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals
002A57 (2009) Bastiaan E. De Galan [Australie, Pays-Bas] ; Vlado Perkovic [Australie] ; Toshiharu Ninomiya [Australie] ; Avinesh Pillai [Australie] ; Anushka Patel [Australie] ; Alan Cass [Australie] ; Bruce Neal [Australie] ; Neil Poulter [Royaume-Uni] ; Stephen Harrap [Australie] ; Carl-Erik Mogensen [Danemark] ; Mark Cooper [Australie] ; Michel Marre [France] ; Bryan Williams [Royaume-Uni] ; Pavel Hamet [Canada] ; Giuseppe Mancia [Italie] ; Mark Woodward [Australie] ; Paul Glasziou [Royaume-Uni] ; Diederick E. Grobbee [Pays-Bas] ; Stephen Macmahon [Australie] ; John Chalmers [Australie]Lowering Blood Pressure Reduces Renal Events in Type 2 Diabetes

List of associated KwdEn.i

Nombre de
documents
Descripteur
6Female
6Humans
6Male
6Middle Aged
5Risk Factors
4Aged
4Diabetes Mellitus, Type 2 (drug therapy)
4Type 2 diabetes
3Antihypertensive Agents (therapeutic use)
3Diabetes Mellitus, Type 2 (complications)
3Drug Combinations
3Hemoglobin A, Glycosylated (metabolism)
3Hypoglycemic Agents (therapeutic use)
3Perindopril (therapeutic use)
2Arterial pressure
2Blood Glucose (metabolism)
2Blood pressure
2Cardiovascular disease
2Diabetes Mellitus, Type 2 (blood)
2Follow-Up Studies
2Gliclazide (therapeutic use)
2Human
2Hypoglycemia (drug therapy)
2Indapamide (therapeutic use)
2Mortality
2Risk Assessment
2Risk factor
2Treatment Outcome
1ACE inhibitor
1Age
1Aldosterone
1Amputation
1Angioplasty
1Angiotensin
1Antihypertensive Agents (adverse effects)
1Biological marker
1Biomarkers (blood)
1Blood Pressure (drug effects)
1Blood Pressure (physiology)
1Brain natriuretic peptide
1Cardiovascular Diseases (prevention & control)
1Case-Control Studies
1Clinical trial
1Cohort Studies
1Complication
1Diabetes Mellitus, Type 2 (diagnosis)
1Diabetes Mellitus, Type 2 (mortality)
1Diabetic Angiopathies (diagnosis)
1Diabetic Angiopathies (etiology)
1Diabetic Angiopathies (mortality)
1Diabetic Angiopathies (therapy)
1Diabetic Retinopathy (etiology)
1Diagnosis
1Duration
1Endocrinology
1Endpoint Determination
1Gliclazide (administration & dosage)
1Gliclazide (adverse effects)
1Heart
1Hypertension
1Hypertension (complications)
1Hypertension (drug therapy)
1Hypoglycemic Agents (adverse effects)
1Incidence
1Indapamide (administration & dosage)
1Indapamide (adverse effects)
1Kidney
1Kidney Diseases (blood)
1Kidney Diseases (etiology)
1Kidney Failure, Chronic (blood)
1Kidney Failure, Chronic (prevention & control)
1Leg Ulcer (etiology)
1Limb Salvage
1Lower Extremity (blood supply)
1Metabolic diseases
1Metabolic precursor
1Microangiopathy
1Microcirculation
1N terminal aminoacid
1Natriuretic Peptide, Brain (blood)
1Nephrology
1Nutrition
1Occlusive arterial disease
1Patient
1Peptide Fragments (blood)
1Perindopril (administration & dosage)
1Perindopril (adverse effects)
1Peripheral Arterial Disease (complications)
1Peripheral Arterial Disease (diagnosis)
1Peripheral Arterial Disease (etiology)
1Peripheral Arterial Disease (mortality)
1Peripheral Arterial Disease (therapy)
1Pharmacogenetics
1Polymorphism
1Precision Medicine (methods)
1Prediction
1Prognosis
1Proportional Hazards Models
1Recurrence
1Renin

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/UK/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Author.i -k "Stephen Harrap" 
HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Author.i  \
                -Sk "Stephen Harrap" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/UK/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    UK
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Stephen Harrap
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024